Search for Clinical Trial Results

Sponsored By

Polyradiculoneuropathy - 50 Studies Found

Status Study
Completed Study Name: Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Date: 2009-11-06
Interventions: Drug: Subcutaneous immunoglobulin The subcutaneous immunoglobulin is infused in the subcutaneous tissue
Completed Study Name: Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.
Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Date: 2012-06-19
Interventions:
  • Drug: Fingolimod
  • Drug: Placebo Comparator
Completed Study Name: Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Date: 2004-12-15
Interventions: Drug: Interferon Beta-1a
Completed Study Name: Study of CIDP Patients During IVIG Treatment
Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Date: 2006-03-20
Interventions: Drug: intravenous gammaglobulin individual dose
Recruiting Study Name: Phase III Efficacy, Safety, and Tolerability Study of HYQVIA/HyQvia and GAMMAGARD LIQUID/KIOVIG in CIDP
Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Date: 2015-09-11
Interventions:
  • Biological: HYQVIA Dosing regi
Not yet recruiting Study Name: Exploratory Study of Predictive Markers of the Therapeutic Response in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Treated With Intravenous Immunoglobulin
Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Date: 2016-08-29
Interventions:
  • Procedure: Muscle Magnetic Resonance Imaging (RMI) evaluation
Completed Study Name: MRI in Diagnosing and Monitoring CIDP
Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Date: 2013-12-06
Recruiting Study Name: Efficacy and Safety Study of I10E in Treatment of Patients With CIDP
Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Date: 2014-11-13
Interventions: Drug: I10E Patients who meet all eligibility criteria will
Recruiting Study Name: Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302
Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Date: 2014-12-11
Interventions: Drug: I10E Patients who met all eligibility criteria will receive 0.5 g/kg of IMP every 3 weeks during 4
Recruiting Study Name: Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP
Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Date: 2016-11-02
Interventions: Biological: HYQVIA Other Names:
  • IGI 10% with rHuPH20
  • Immune Gl
Next >>>